Russian Journal of Bioorganic Chemistry, volume 49, issue 6, pages 1216-1228
Radiopharmaceuticals for Non-Glucose-Specific Oncology (PET and SPECT) (A Review)
Belitskaya E. D.
1, 2
,
Dimitreva V. A.
1, 2
,
Kozlov A.N.
1
,
Oleinikov V A
1, 2
,
Zalygyn A. V.
1, 2
Publication type: Journal Article
Publication date: 2023-11-23
Quartile SCImago
Q4
Quartile WOS
Q4
Impact factor: 1
ISSN: 10681620, 1608330X
Organic Chemistry
Biochemistry
Abstract
To date, the most common drug for diagnosis of cancer tumors is [18F]-fluorodeoxyglucose, a radiopharmaceutical for positron emission tomography, which utilizes an increased glucose metabolism by cancer cells. At the same time, the approach based on glucose derivatives is not applicable in some cases. Inflammatory or other benign processes are often indistinguishable from tumors when the tumor is not specific to glucose, i.e., not only the malignant but also healthy cells actively consume [18F]-fluorodeoxyglucose. In these cases, it is necessary to utilize other metabolic pathways, which can be specific to radiopharmaceuticals for a specific tumor in a given organ.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Belitskaya E. D. et al. Radiopharmaceuticals for Non-Glucose-Specific Oncology (PET and SPECT) (A Review) // Russian Journal of Bioorganic Chemistry. 2023. Vol. 49. No. 6. pp. 1216-1228.
GOST all authors (up to 50)
Copy
Belitskaya E. D., Dimitreva V. A., Kozlov A., Oleinikov V. A., Zalygyn A. V. Radiopharmaceuticals for Non-Glucose-Specific Oncology (PET and SPECT) (A Review) // Russian Journal of Bioorganic Chemistry. 2023. Vol. 49. No. 6. pp. 1216-1228.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1134/s1068162023060043
UR - https://doi.org/10.1134%2Fs1068162023060043
TI - Radiopharmaceuticals for Non-Glucose-Specific Oncology (PET and SPECT) (A Review)
T2 - Russian Journal of Bioorganic Chemistry
AU - Belitskaya, E. D.
AU - Dimitreva, V. A.
AU - Kozlov, A.N.
AU - Oleinikov, V A
AU - Zalygyn, A. V.
PY - 2023
DA - 2023/11/23 00:00:00
PB - Pleiades Publishing
SP - 1216-1228
IS - 6
VL - 49
SN - 1068-1620
SN - 1608-330X
ER -
Cite this
BibTex
Copy
@article{2023_Belitskaya,
author = {E. D. Belitskaya and V. A. Dimitreva and A.N. Kozlov and V A Oleinikov and A. V. Zalygyn},
title = {Radiopharmaceuticals for Non-Glucose-Specific Oncology (PET and SPECT) (A Review)},
journal = {Russian Journal of Bioorganic Chemistry},
year = {2023},
volume = {49},
publisher = {Pleiades Publishing},
month = {nov},
url = {https://doi.org/10.1134%2Fs1068162023060043},
number = {6},
pages = {1216--1228},
doi = {10.1134/s1068162023060043}
}
Cite this
MLA
Copy
Belitskaya, E. D., et al. “Radiopharmaceuticals for Non-Glucose-Specific Oncology (PET and SPECT) (A Review).” Russian Journal of Bioorganic Chemistry, vol. 49, no. 6, Nov. 2023, pp. 1216-1228. https://doi.org/10.1134%2Fs1068162023060043.
Profiles